MediPharm Labs (TSE:LABS) Reaches New 12-Month Low – Should You Sell?

MediPharm Labs Corp. (TSE:LABSGet Free Report)’s stock price hit a new 52-week low during mid-day trading on Friday . The company traded as low as C$0.06 and last traded at C$0.07, with a volume of 206733 shares trading hands. The stock had previously closed at C$0.07.

MediPharm Labs Price Performance

The stock has a market cap of C$26.72 million, a PE ratio of -1.63 and a beta of 0.88. The company has a current ratio of 3.11, a quick ratio of 3.10 and a debt-to-equity ratio of 5.90. The business has a 50-day moving average price of C$0.07 and a 200-day moving average price of C$0.07.

MediPharm Labs Company Profile

(Get Free Report)

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.

Further Reading

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.